Is MetLife, Inc. (MET) Overvalued?
We dive into why MetLife, Inc. (MET) could be considered overvalued on 2026-07-16, based on AAII’s Value Score and Grade.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.
Commentary & Analysis
Which Is a Better Investment, Cincinnati Financial Corporation or MetLife, Inc. Stock?
Learn more about whether Cincinnati Financial Corporation or MetLife, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Rosalio Madrigal
4 Undervalued Insurance Stocks for Thursday, July 02
Discover the top 4 undervalued Insurance stocks for Thursday, July 02 based on AAII’s Stock Grades.Rosalio Madrigal
What You Need to Know About MetLife, Inc.'s Q2 Earnings
MetLife, Inc.'s fiscal Q2 earnings report was released on Wednesday, May 06. Let's dive in to see if (MET) missed or beat analyst's expectations.Tudor Pop
Is MetLife, Inc. (MET) Stock a Good Investment?
Learn more about MetLife, Inc.'s (MET) stock grades for Value, Momentum, Growth and Estimate Revisions and determine whether this Insurance stock meets your investment needs.Jenna Brashear
Financial Summary
| Share Statistics | MET | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $61,853.6 | $7,055.8 | 94% |
|
| Shares Out (Mil) | 655.7 | 66.0 | 91% |
|
| Institutional Ownership | 99.7% | 81.8% | 93% |
|
| Float (Mil) | 537.5 | 67.4 | 86% |
|
| Beta | 0.78 | 0.52 | 46% |
|
| Avg Daily Volume (000s) | 4,588 | 186 | 92% |
|
| Price Change (52-week) |
28.5% | 90.4% | 68% |
|
| Growth | MET | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 2.6% | 5.6% | 25% |
|
| Net Income (5yr) | (9.0%) | 14.5% | 30% |
|
| EPS (5yr) | (3.7%) | 15.6% | 26 |
|
| Dividends (5yr) | 4.3% | 3.8% | 91% |
|
| Cash Flow (5yr) | (7.6%) | (14.5%) | 60% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 15 | 17 | 17 | |
| Current EPS | $2.289 | $9.852 | $10.988 | |
| Month Ago EPS | $2.358 | $9.908 | $11.006 | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 1 | 0 | |
| Three Months Ago EPS | $2.441 | $9.807 | $10.956 | |
| Year/Year Chg | 31.6% | 109.2% | 160.2% | |
| Financials | MET | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $77,584 | $5,065 | 98% |
|
| Net Income (TTM) (Mil) | $3,619 | $534 | 96% |
|
| EPS (TTM) | $5.193 | $2.500 | 87% |
|
| Operating Cash Flow (TTM) (Mil) | $15,517 | $499 | 99% |
|
| Net Cash Flow (TTM) (Mil) | $1,361 | $3 | 96% |
|
| Long-Term Debt (Q1) (Mil) | $27,125 | $844 | 97% |
|
| Enterprise Value (Q1) (Mil) | $86,265 | $7,585 | 95% |
|
| Valuation | MET | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.27 | 1.77 | 55% |
|
| P/E | 18.6 | 12.9 | 47% |
|
| Dividend Yield | 2.4% | 0.9% | 79% |
|
| PEG (5yr hist) | na | 0.5 | na |
|
| Ratios | MET | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 23.8% | 33.4% | 26% |
|
| Net Margin | 4.7% | 9.9% | 47% |
|
| ROA | 0.5% | 2.7% | 42% |
|
| ROE | 13.2% | 14.8% | 67% |
|
| Liabilities to Assets | 96.3% | 76.7% | 93% |
|
| F-Score | 7 | 6 | 84% |
|
Passing Stock Screens
As of 7/31/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Kirkpatrick Bargain Screen
Factors: Value, Momentum
Investing model outlined in Charles Kirkpatrick's book, Beat the Market: Invest by Knowing What Stocks to Buy and What Stocks to Sell.
| Performance Since Inception: | 6.8% |
| +/- S&P 500: | -0.7 |
